Weiqiang Zhao MD PhD, FCAP
Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology
Professor of Pathology, Ohio State University College of Medicine Columbus, OH Medical Director, James Molecular Laboratory at Polaris Medical Director, Cytogenetics Lab, James Cancer Center/Hospital
Join to view full profile
2001 Polaris PkwyColumbus, OH 43240
Phone+1 614-366-7015
Fax+1 614-293-7013
Dr. Zhao is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Weiqiang Zhao is a pathologist in Columbus, OH affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from Hunan Medical University and has been in practice 35 years. He also speaks multiple languages, including Chinese (Mandarin). He specializes in hematopathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in the diagnosis of acute myeloid leukemia, lymphoma, non-small cell lung cancer, acute lymphoblastic leukemia, and myeloproliferative neoplasms.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Molecular Genetic Pathology, 2006 - 2007
Tulane UniversityFellowship, Hematopathology, 2005 - 2006- Tulane UniversityResidency, Pathology-Anatomic and Clinical, 2003 - 2005
Hunan Medical UniversityClass of 1982
Certifications & Licensure
OH State Medical License 2007 - 2027
LA State Medical License 2004 - 2007
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma.Thurbu Tshering Lepcha, Nithya Paruchuri, Dawei Zhou, Guillaume N Fiches, Jinshan He
Biorxiv. 2026-08-08 - Optimizing bioinformatic workflows to extract clinically usable gene expression data from targeted tumor RNA sequencing panels: comparison with total RNA-seq in cancer...Xiaokang Pan, Ashley Patton, Yi Seok Chang, Ryan Stevens, Nehad Mohamed
Bioinformatics Advances. 2026-01-01 - 1 citationsInstability in the Penta-C and Penta-D Loci in Microsatellite-Unstable Endometrial Cancer.Ahmet Yilmaz, Wendy L Frankel, Weiqiang Zhao, Adrian A Suarez, Wei Chen
International Journal of Environmental Research and Public Health. 2025-11-04
Journal Articles
- Givinostat, A Type II Histone Deacetylase Inhibitor, Induces Potent Caspase-Dependent Apoptosis in Human Lymphoblastic Leukemia.Li Ying, K Zhao, C Yao, S Kahwash, Y Tang, G Zhang, K Patterson, Qi-En Wang, W Zhao, Genes & Cancer, 9/24/2016
Press Mentions
Multi-Gene Testing Could Detect More Hereditary Cancer SyndromesMay 10th, 2021
Committees
- Committee Scientific Expert, Committee to Review the Styrene Assessment in the National Toxicology Program 12th Report on Carcinogens, National Academies, Board of Environmental Studies and Toxicology, Washington DC. 2013 - 2014
Professional Memberships
- Member
- Member
- Fellow
- Fellow
Other Languages
- Chinese (Mandarin)
External Links
- Dr. Zhaohttps://pathology.osu.edu/ext/faculty/zhao.html
- OSU Molecular Laboratorieshttps://pathology.osu.edu/ext/divisions/Clinical/molpath/default.htm#faculty
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
